Glen Tullman

Tullman was born in 1959, near Chicago, Illinois and is the youngest of six children.^[3] He and his family moved to New Jersey when he was in fourth grade, and he graduated from New Providence High School in 1977.^[4] Tullman received his undergraduate degree in 1981 in economics and psychology from Bucknell University.^[3] He also spent a year in Oxford, England studying social anthropology.^[3]

After graduation, Tullman joined Certified Collateral Corporation (later called CCC Information) in Illinois, where he worked for approximately 10 years in a number of roles.^[5] Ultimately, he was President and Chief Operating Officer of the company, and lead them to grow from $30 million to $100 million.^[5] After working at CCC Information, he joined Enterprise Systems as CEO, leading it through its initial public offering and eventual sale to McKesson Corporation.^[3][6]

In 1997, Tullman became the CEO of Allscripts, a turnaround which he built into a major provider of electronic prescribing, practice management and electronic health records.^[3] He was the CEO of the company for 15 years prior to leaving in 2012.^[3][7] Tullman led the company’s Initial Public Offering and was the first CEO once it went public.^[3][8]

After leaving Allscripts, Tullman co-founded and became the managing partner at 7Wire Ventures, the leading early stage digital health venture capital firm with more than $500 million AUM.^[9]

Tullman has invested in and/or co-founded more than 20 businesses throughout his career,^[7] including SoCore Energy, a commercial solar panel installation company that was later purchased by Edison International.^[10] He also founded a classroom technology company called Modern Teacher, now part of LEAP Innovations.^[11][12]

In 2014, Tullman founded Livongo, a digital health company that provides connected devices and health platforms for people with chronic conditions like diabetes, and other medical conditions.^[13] When Tullman's son Sam was diagnosed with type 1 diabetes at 8 years old, he saw a market need for such patients.^[14] Livongo went public in 2019^[15] and was then sold to Teladoc Health for $18.5B in 2020.^[16] Afterward, Tullman resigned from the Teladoc board in 2020.^[17]

Since 2021, Tullman has been Chief Executive Officer and Founder of Transcarent, a consumer-directed health and care platform which offers information about benefits, medication savings and personalized care for self-insured employers, their employees and their families in the United States.^[18] The company aims to enable increased access to high-quality, affordable health and care for members of these parties.^[19]

Tullman was a Forbes contributor through 2016,^[20] and in 2021 Tullman was named a Forbes Healthcare Top 10 Leader of the Decade.^[21] He is the author of the book On Our Terms: Empowering the New Health Consumer.^[22]

In 2024, Tullman founded a $100M venture fund named 62 Ventures, to invest in startups outside of 7wire Ventures. 62 Ventures focuses on education, health and care, environmental sustainability, and other sectors.^[23]

Tullman has held various executive positions outside of Transcarent. He is an Illinois Life Director for Breakthrough T1D (formerly JDRF),^[24] and was a board member of the American Diabetes Association.

Alongside his daughter, Cayley Tull, he is the co-founder of the Tullman Family Office (TFO).

In 2019, Tullman was presented with a Robert F. Kennedy Human Rights Ripple of Hope Award.^[25]